SOLID DISPERSION COMPRISING AN ANTICANCER COMPOUND FOR IMPROVED SOLUBILITY AND EFFICACY

The present invention is related to the novel solid dispersion formulations of an anticancer compound of formula A and a process for preparing the same wherein the anticancer compound is formulated with hydrophilic polymer. The said formulation showed enhanced dissolution of the anticancer compound and improved in-vivo anticancer activity. The said formulations are useful for the treatment of various types of cancer..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 19. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

BHARATE SONALI SANDIP [VerfasserIn]
KUMAR VIKAS [VerfasserIn]
MINTOO MUBASHIR JAVED [VerfasserIn]
MONDHE DILIP MANIKRAO [VerfasserIn]
BHARATE SANDIP BIBISHAN [VerfasserIn]
VISHWAKARMA RAM [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-19, Last update posted on www.tib.eu: 2024-04-15, Last updated: 2024-04-19

Patentnummer:

CA3099901

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000381047